DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aplenzin (Bupropion) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Aplenzin (Bupropion) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (3)

Reports by Reaction Type

Photosensitivity Reaction (1)Product Substitution Issue (1)Urticaria (1)Depression (1)Atrial Fibrillation (1)Condition Aggravated (1)Rash (1)NO Therapeutic Response (1)

Possible Aplenzin side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-31

Patient: male, weighing 97.5 kg (214.6 pounds)

Reactions: Atrial Fibrillation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diltiazem HCL
    Dosage: (120 mg, daily oral), (240 mg, daily oral)
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2011-09-01

Aplenzin
    Dosage: (522 mg qd)
    Indication: Depression
    Start date: 2009-12-01

Other drugs received by patient: Ramipril; Simvastatin; Zolpidem; Atorvastatin Calcium



Possible Aplenzin side effects in female

Reported by a physician from United States on 2012-02-27

Patient: female

Reactions: Product Substitution Issue, NO Therapeutic Response, Condition Aggravated, Depression

Drug(s) suspected as cause:
Wellbutrin
    Dosage: 300mg qd

Aplenzin
    Dosage: 348 q day

Other drugs received by patient: Lamictal



Possible Aplenzin side effects in 55 year old female

Reported by a consumer/non-health professional from United States on 2011-10-17

Patient: 55 year old female, weighing 68.0 kg (149.7 pounds)

Reactions: Photosensitivity Reaction, Urticaria, Rash

Drug(s) suspected as cause:
Aplenzin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012